Illinois Municipal Retirement Fund’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$914K Sell
62,734
-49,160
-44% -$872K 0.01% 925
2026
Q1
$2.12M Buy
111,894
+12,527
+13% +$203K 0.03% 565
2025
Q4
$1.74M Buy
99,367
+30,694
+45% +$577K 0.02% 630
2025
Q3
$1.42M Buy
68,673
+37,611
+121% +$912K 0.02% 724
2025
Q2
$661K Buy
+31,062
New +$708K 0.01% 1016

Other funds holding SMMT

Illinois Municipal Retirement Fund's SMMT Position: Q2 2026 in Review

Illinois Municipal Retirement Fund reduced its Summit Therapeutics (SMMT) stake by 44% in Q2 2026, selling an estimated $872K and leaving 62,734 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #925.

Illinois Municipal Retirement Fund first reported a position in SMMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.12M in Q1 2026. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Illinois Municipal Retirement Fund held 62,734 shares of Summit Therapeutics worth $914K as of Q2 2026.
  • Illinois Municipal Retirement Fund sold 49,160 Summit Therapeutics shares in Q2 2026, an estimated $872K.
  • Summit Therapeutics made up 0.01% of Illinois Municipal Retirement Fund's portfolio in Q2 2026, its #925 holding.
  • Illinois Municipal Retirement Fund first reported a position in Summit Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Illinois Municipal Retirement Fund's Summit Therapeutics position peaked at $2.12M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Illinois Municipal Retirement Fund's 13F filing for Q2 2026, filed 12 Aug 2026.